IFSO Position Statement on New Technologies for Treatment of Obesity
暂无分享,去创建一个
J. Himpens | E. Wilson | R. Vilallonga | K. Higa | D. Portenier | N. Zundel | J. Dargent | Leon Katz | Alex Esacalona
[1] C. Thompson,et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. , 2015, Gastrointestinal endoscopy.
[2] Nitin Kumar. Endoscopic therapy for weight loss: Gastroplasty, duodenal sleeves, intragastric balloons, and aspiration. , 2015, World journal of gastrointestinal endoscopy.
[3] L. Busetto. Reply to a Letter to the Editor: Bariatric Surgery in Class I Obesity. A Position Statement from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO)—Obesity Surgery 2014;24:487–519 , 2015, Obesity Surgery.
[4] A. Zinsmeister,et al. Quantitative gastrointestinal and psychological traits associated with obesity and response to weight-loss therapy. , 2015, Gastroenterology.
[5] J. Lipton,et al. Ribosomopathy association with colorectal cancer. , 2015, Gastroenterology.
[6] J. Dixon,et al. Bariatric Surgery in Class I Obesity , 2014, Obesity Surgery.
[7] Shein-Chung Chow,et al. Adaptive clinical trial design. , 2014, Annual review of medicine.
[8] J. Dixon,et al. Promises and Ethical Pitfalls of Surgical Innovation: the Case of Bariatric Surgery , 2013, Obesity Surgery.